"Through a cooperative agreement with the U.S. Food and Drug Administration, this public workshop will examine the complexities of stimulant use disorder with a focus on methamphetamine and cocaine abuse. The goals of this workshop are to explore emerging trends in illicit and prescription stimulant abuse, review drug development paradigms for novel treatments, and explore potential innovative therapies for stimulant use disorder. Participants will discuss future directions for drug development and regulation as well as strategies for patient engagement. This meeting will bring together experts and key stakeholders from federal agencies, academia, and professional organizations. This workshop will lay the groundwork for understanding this complex landscape and promoting the exchange of innovative ideas to advance the development of novel therapies for stimulant use disorder."